Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypoxia and Inflammatory Injury in Human Renovascular Hypertension : Phase 1 Trial of Mesenchymal Stem Cell Therapy

NCT02266394 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02266394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02266394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypoxia and Inflammatory Injury in Human Renovascular Hypertension : Phase 1 Trial of Mesenchymal Stem Cell Therapy
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
October 21, 2014
Completion date
September 25, 2020
Enrollment
42 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, ischemic nephropathy, renal artery stenosis, renovascular disease